Synergy CHC (NASDAQ:SNYR – Get Free Report) and Procter & Gamble (NYSE:PG – Get Free Report) are both consumer staples companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, risk, profitability, analyst recommendations, valuation, earnings and dividends.
Profitability
This table compares Synergy CHC and Procter & Gamble’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Synergy CHC | 7.77% | -19.51% | 14.25% |
| Procter & Gamble | 19.74% | 32.63% | 13.53% |
Risk and Volatility
Synergy CHC has a beta of 3.48, meaning that its share price is 248% more volatile than the S&P 500. Comparatively, Procter & Gamble has a beta of 0.39, meaning that its share price is 61% less volatile than the S&P 500.
Valuation & Earnings
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Synergy CHC | $34.83 million | 0.59 | $2.12 million | $0.29 | 6.28 |
| Procter & Gamble | $84.93 billion | 3.97 | $15.97 billion | $6.85 | 21.06 |
Procter & Gamble has higher revenue and earnings than Synergy CHC. Synergy CHC is trading at a lower price-to-earnings ratio than Procter & Gamble, indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations
This is a summary of current ratings and target prices for Synergy CHC and Procter & Gamble, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Synergy CHC | 0 | 1 | 2 | 0 | 2.67 |
| Procter & Gamble | 0 | 10 | 15 | 0 | 2.60 |
Synergy CHC currently has a consensus target price of $8.50, suggesting a potential upside of 367.03%. Procter & Gamble has a consensus target price of $169.23, suggesting a potential upside of 17.33%. Given Synergy CHC’s stronger consensus rating and higher possible upside, analysts plainly believe Synergy CHC is more favorable than Procter & Gamble.
Insider & Institutional Ownership
65.8% of Procter & Gamble shares are held by institutional investors. 56.6% of Synergy CHC shares are held by insiders. Comparatively, 0.2% of Procter & Gamble shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Summary
Procter & Gamble beats Synergy CHC on 9 of the 14 factors compared between the two stocks.
About Synergy CHC
Synergy CHC Corp. engages in the marketing and distribution of branded health and wellness products. The company was founded on December 29, 2010 and is headquartered in Westbrook, ME.
About Procter & Gamble
Procter & Gamble Co. engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances. The Health Care segment includes oral care products like toothbrushes, toothpaste, and personal health care such as gastrointestinal, rapid diagnostics, respiratory, and vitamins, minerals, and supplements. The Fabric and Home care segment consists of fabric enhancers, laundry additives and detergents, and air, dish, and surface care. The Baby, Feminine and Family Care segment sells baby wipes, diapers, and pants, adult incontinence, feminine care, paper towels, tissues, and toilet paper. The company was founded by William Procter and James Gamble in 1837 and is headquartered in Cincinnati, OH.
Receive News & Ratings for Synergy CHC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synergy CHC and related companies with MarketBeat.com's FREE daily email newsletter.
